How to Get Qalsody (Tofersen) Covered by UnitedHealthcare in North Carolina: Prior Authorization, Appeals, and State Review Guide
Answer Box: Getting Qalsody Covered by UnitedHealthcare in North Carolina
Eligibility: UnitedHealthcare covers Qalsody (tofersen) for ALS patients with confirmed SOD1 mutations, but requires prior authorization through OptumRx. The medication sits on Specialty Tier with 30-50% coinsurance.
Fastest Path: 1) Gather SOD1 genetic test results and baseline ALSFRS-R scores, 2) Submit PA via professionals.optumrx.com or call 1-800-711-4555, 3) If denied, use North Carolina's Smart NC external review (1-855-408-1212) within 120 days.
Start Today: Contact your neurologist to confirm SOD1 testing is complete and request they initiate the prior authorization process with all required documentation.
Table of Contents
- UnitedHealthcare Plan Types in North Carolina
- Qalsody Formulary Status and Tier Placement
- Prior Authorization Requirements
- Specialty Pharmacy Network
- Cost-Sharing and Financial Assistance
- Submission Process and Forms
- Common Approval Patterns
- Appeals Process: Internal and North Carolina External Review
- When to Contact Smart NC
- FAQ
UnitedHealthcare Plan Types in North Carolina
North Carolina offers several UnitedHealthcare plan options, each with different coverage rules for specialty medications like Qalsody.
Medicaid Plans
UnitedHealthcare Community Plan of North Carolina covers Medicaid beneficiaries and does not require referrals for specialty care, including neurology services. This changed in November 2016 when North Carolina eliminated PCP referral requirements for specialty care. However, individual neurologist offices may still request referrals as their own policy.
Medicare Advantage Plans
Starting in 2026, UnitedHealthcare Medicare Advantage plans will require referrals for most specialists, submitted by your PCP prior to visits. This change doesn't apply in Nevada, California, or Texas. The 2025 Medicare reforms also introduced a $2,000 annual out-of-pocket maximum for prescription medications.
Commercial Plans (HMO/PPO/EPO)
Commercial UnitedHealthcare plans in North Carolina follow standard network rules. Verify your specific plan's neurologist network and referral requirements by calling member services at 877-842-3210.
Qalsody Formulary Status and Tier Placement
Qalsody (tofersen) is classified as a Specialty Tier medication across UnitedHealthcare formularies. This highest-cost tier typically carries 30-50% coinsurance after deductible for commercial plans, though Medicaid members may have minimal or zero cost-sharing.
Alternative Medications
Limited alternatives exist for SOD1-ALS specifically. Standard ALS treatments include riluzole and edaravone, but these are not targeted to SOD1 pathology and are insufficient alternatives for this genetic subtype.
Step Therapy Considerations
If UnitedHealthcare requires step therapy, your neurologist can request a medical necessity exception by documenting:
- Clinical inappropriateness of alternatives for SOD1-ALS
- Expected ineffectiveness of other medications for the genetic subtype
- Risk of irreversible progression during therapy delays
Prior Authorization Requirements
All UnitedHealthcare plans require prior authorization for Qalsody through OptumRx. The median approval time has improved to 29 seconds for automated approvals, though complex cases may take longer.
Coverage Requirements Table
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| SOD1 mutation confirmed | Pathogenic SOD1 variant documented | Genetic testing from Quest, LabCorp, or specialty lab | UHC Policy |
| ALS diagnosis | Clinical confirmation by neurologist | Neurologist's clinical notes and EMG results | UHC Policy |
| Baseline ALSFRS-R score | Functional assessment documented | Clinic visit notes | UHC Policy |
| No invasive ventilation | Patient not ventilator-dependent | Current clinical assessment | UHC Policy |
| Neurologist prescriber | ALS-experienced neurologist | Board certification verification | UHC Policy |
Specialty Pharmacy Network
UnitedHealthcare typically requires specialty medications to be filled through their preferred specialty pharmacy network, usually Optum Specialty Pharmacy. Using an out-of-network specialty pharmacy may result in higher costs or no coverage.
Specialty Pharmacy Support: Call 1-855-427-4682 for assistance. Pharmacists and patient care coordinators are available 24/7 to transfer prescriptions and find affordable cost options.
Cost-Sharing and Financial Assistance
Annual Costs
Qalsody's list price ranges from $14,230–$14,754 per 100mg vial. First-year drug costs typically reach $200,000–$220,000 (15 doses), with subsequent years around $170,000–$180,000 annually.
Financial Assistance Options
- Qalsody Direct: Call 1-833-777-7266 for coverage verification and copay assistance
- Biogen Patient Assistance: May provide free medication for eligible uninsured patients
- Medicare Prescription Payment Plan: Spreads costs at approximately $167 monthly instead of large upfront payments
Important: Manufacturer copay assistance programs do not count toward your $2,000 out-of-pocket maximum under Medicare Part D plans. Only amounts you personally pay count toward this threshold.
Submission Process and Forms
Step-by-Step: Fastest Path to Approval
- Gather Documentation (Patient/Clinic): Collect SOD1 genetic test results, baseline ALSFRS-R scores, ALS diagnosis confirmation, and current ventilation status
- Submit Prior Authorization (Neurologist): Use professionals.optumrx.com or call 1-800-711-4555
- Follow Up (Clinic): Check status within 48-72 hours and respond quickly to information requests
- Peer-to-Peer Review (If needed): Have genetic testing results and FDA prescribing information organized
- Appeal if Denied (Patient/Clinic): File internal appeal within 180 days
- External Review (Patient): Contact Smart NC at 1-855-408-1212 within 120 days if internal appeals fail
- Expedited Review (If urgent): Request expedited review for rapid functional decline cases
Common Approval Patterns
Strong submissions typically include:
- Complete SOD1 mutation documentation upfront
- Comprehensive baseline functional assessments
- Clear neurologist consultation notes
- FDA prescribing information attachment
- Documentation of rapid disease progression when applicable
Clinician Corner: Medical Necessity Letter Checklist
Your neurologist's prior authorization letter should include:
- Problem: Confirmed ALS diagnosis with attached SOD1 mutation results
- Prior Treatments: History with riluzole, edaravone, or other ALS medications
- Clinical Rationale: FDA approval for SOD1-ALS and mechanism of action
- Guideline Citations: FDA labeling and recent CMS guidance on SOD1-ALS coverage
- Dosing: Standard intrathecal 100mg loading and maintenance schedule
- Monitoring: Plan for ALSFRS-R and NfL tracking
Appeals Process: Internal and North Carolina External Review
Internal Appeals with UnitedHealthcare
- Timeline: 180 days from denial to file internal appeal
- Process: Submit through UnitedHealthcare Provider Portal or member services
- Decision Time: 30 days for standard review, 72 hours for urgent cases
- Levels: Typically 1-2 internal appeal levels before external review
Common Denial Reasons & Solutions
| Denial Reason | How to Overturn | Required Documentation |
|---|---|---|
| No SOD1 mutation documented | Submit genetic testing results | Laboratory report showing pathogenic SOD1 variant |
| Not prescribed by neurologist | Obtain specialist consultation | Board-certified neurologist prescription |
| Experimental/investigational | Cite FDA approval and CMS guidance | FDA label and CMS December 2024 directive |
| Missing baseline assessments | Provide comprehensive data | ALSFRS-R scores, NfL levels, pulmonary function tests |
| Invasive ventilation documented | Document current status | Confirmation patient is not invasively ventilated |
When to Contact Smart NC
North Carolina's Smart NC program provides exceptional support for insurance appeals and external review. Contact them at 1-855-408-1212 when:
External Review Process
- Eligibility: State-regulated plans (not self-funded employer plans unless opted in)
- Timeline: 120 days after final internal appeal denial
- Decision Time: 45 days for standard cases, 72 hours for expedited reviews
- Cost: Free to patients
- Binding Decision: If approved, insurer must provide coverage within 3 business days
Smart NC Advocacy Support
Smart NC staff can help you:
- Fill out external review request forms
- Gather medical records and supporting documentation
- Communicate with your insurer
- Find clinical guidelines and medical articles to support your case
- Navigate the appeals process step-by-step
Tip: Smart NC can waive the internal appeal requirement for expedited external reviews in urgent situations, ensuring you don't waste precious time when rapid functional decline is documented.
Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals for medications like Qalsody. Our platform identifies denial reasons and drafts point-by-point rebuttals aligned to payer policies, pulling the right citations and clinical facts to strengthen your case. Learn more about our services.
FAQ
How long does UnitedHealthcare prior authorization take in North Carolina? OptumRx has improved approval times significantly, with a median of 29 seconds for automated approvals. Complex cases requiring clinical review typically take 1-3 business days.
What if Qalsody is denied as experimental? Cite FDA approval for SOD1-ALS and the December 2024 CMS directive requiring Medicare Advantage plans to cover Qalsody for on-label use. This is a strong appeal hook.
Can I request an expedited appeal? Yes, if delays would seriously jeopardize your health or ability to regain function. Document rapid functional decline to qualify for expedited review (72 hours in North Carolina).
Does step therapy apply if I failed treatments outside North Carolina? Previous treatment history with riluzole or edaravone from other states should count toward step therapy requirements. Provide documentation of prior trials and outcomes.
What happens if my neurologist isn't in UnitedHealthcare's network? Out-of-network neurologists can still prescribe Qalsody, but you may face higher costs. Consider obtaining a consultation from an in-network neurologist to support the prescription.
How do I verify my current formulary tier and copay? Log into your UnitedHealthcare member portal or call member services at the number on your insurance card to verify current tier placement and estimated costs.
For patients and clinicians navigating complex prior authorization requirements, Counterforce Health offers specialized support in building evidence-backed appeals that align with payer policies and improve approval rates for specialty medications.
Sources & Further Reading
- UnitedHealthcare Qalsody Policy
- OptumRx Prior Authorization Guidelines
- North Carolina Smart NC Program
- CMS Qalsody Coverage Guidance
- FDA Qalsody Prescribing Information
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage policies and requirements may change. Always verify current information with UnitedHealthcare, your healthcare provider, and North Carolina insurance regulators before making treatment decisions.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.